{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:17:47Z","timestamp":1757542667966},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1992,6,1]],"date-time":"1992-06-01T00:00:00Z","timestamp":707356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1992,6]]},"DOI":"10.1007\/bf01300384","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T06:39:50Z","timestamp":1111732790000},"page":"865-874","source":"Crossref","is-referenced-by-count":16,"title":["Nizatidine versus placebo in gastroesophageal reflux disease"],"prefix":"10.1007","volume":"37","author":[{"given":"Michelle L.","family":"Cloud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter W.","family":"Offen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The Nizatidine Gastroesophageal Reflux disease Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0002-9343(89)90444-0","volume":"86","author":"NK Altorki","year":"1989","unstructured":"Altorki NK, Skinner DB: Pathophysiology of gastroesophageal reflux. Am J Med 86:685?689, 1989","journal-title":"Am J Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0889-8553(21)00678-6","volume":"18","author":"CP Ogorek","year":"1989","unstructured":"Ogorek CP, Cohen S: Gastroesophageal reflux disease: New concepts in pathophysiology. Gastroenterol Clin Am 18:275?292, 1989","journal-title":"Gastroenterol Clin Am"},{"issue":"suppl 1","key":"CR3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00004836-198606001-00005","volume":"8","author":"A Dubois","year":"1986","unstructured":"Dubois A: Clinical relevance of gastroduodenal dysfunction in reflux esophagitis. J Clin Gastroenterol 8(suppl 1):17?25, 1986","journal-title":"J Clin Gastroenterol"},{"issue":"suppl 156","key":"CR4","first-page":"25","volume":"24","author":"HR Koelz","year":"1989","unstructured":"Koelz HR: Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs: An analysis of randomized clinical trials. Scand J Gastroenterol 24(suppl 156): 25?36, 1989","journal-title":"Scand J Gastroenterol"},{"key":"CR5","first-page":"245","volume":"84","author":"R Stalnikowicz-Darvasi","year":"1989","unstructured":"Stalnikowicz-Darvasi R: H2 antagonists in the treatment of reflux esophagitis: A critical analysis. Am J Gastroenterol 84:245?248, 1989","journal-title":"Am J Gastroenterol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0016-5085(86)80017-8","volume":"91","author":"HR Koelz","year":"1986","unstructured":"Koelz HR, Birchler R, Bretholz A, Bron B, Capitaine Y, Delmore G, Fehr HF, Fumagalli I, Gehrig J, Gonvers J, Halter B, Hammer B, Kayasseh L, Kobler E, Miller G, M\u00fcnst G, Pelloni S, Realini S, Schmid P, Voirol M, Blum AL: Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 91:1198?1205, 1986","journal-title":"Gastroenterology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2165\/00003495-198836050-00002","volume":"36","author":"AH Price","year":"1988","unstructured":"Price AH, Brogden RN: Nizatidine: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. Drugs 36:521?539, 1988","journal-title":"Drugs"},{"key":"CR8","unstructured":"Cloud ML, Offen WW, Nizatidine Gastroesophageal Reflux Disease Study Group: Nizatidine versus placebo in gastroesophageal reflux disease: A 12-week, multicenter, randomized, double-blind study. Am J Gastroenterol (in press)"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2307\/2528901","volume":"25","author":"JE Grizzle","year":"1969","unstructured":"Grizzle JE, Starmer CF, Koch GG: Analysis of categorical data by linear models. Biometrics 25:489?504, 1969","journal-title":"Biometrics"},{"key":"CR10","first-page":"668","volume":"11","author":"JP Pignon","year":"1987","unstructured":"Pignon JP, Poynard T, Naveau S, Seberg G, Chaput JC: Traitement du reflux gastro-oesophagien: Analyse des essais randomiss en double aveugle. Gastroenterol Clin Biol 11:668?680, 1987","journal-title":"Gastroenterol Clin Biol"},{"key":"CR11","first-page":"253","volume":"15","author":"O Ghidini","year":"1989","unstructured":"Ghidini O, Adamo S: Validity of high-dose ranitidine treatment (300 mg b.i.d.) in clinical practice: an open study in 68 consecutive cases of severe peptic disease. Drugs Exp Clin Res 15:253?258, 1989","journal-title":"Drugs Exp Clin Res"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0016-5085(89)90073-5","volume":"97","author":"S Bates","year":"1989","unstructured":"Bates S, Sjoden P-O, Fellenius J, Nyren O: Blocked and nonblocked acid secretion and reported pain in ulcer, nonulcer dyspepsia, and normal subjects. Gastroenterology 97:376?383, 1989","journal-title":"Gastroenterology"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0016-5085(89)90890-1","volume":"96","author":"JL Smith","year":"1989","unstructured":"Smith JL, Opekun AR, Larkai E, Graham DY: Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 96:683?689, 1989","journal-title":"Gastroenterology"},{"key":"CR14","first-page":"217","volume":"4","author":"JP Desechalliers","year":"1984","unstructured":"Desechalliers JP, Galmiche JP, Touchais JY, Denis P, Colin R: Ranitidine, cimetidine, antacids, and gastrooesophageal reflux: Results of a 20-hour oesophageal pH study. Int J Clin Pharmacol Res 4:217?222, 1984","journal-title":"Int J Clin Pharmacol Res"},{"issue":"suppl 166","key":"CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00365528909091240","volume":"24","author":"L Olbe","year":"1989","unstructured":"Olbe L, Cederberg C, Lind T, Olausson M: Effect of omeprazole on gastric acid secretion and plasma gastrin in man. Scand J Gastroenterol 24(suppl 166), 27?32, 1989","journal-title":"Scand J Gastroenterol"},{"key":"CR16","doi-asserted-by":"crossref","unstructured":"Johnson MJ, Mills JG, Wood JR: Acute treatment of reflux esophagitis: A multi-centre trial comparing ranitidine 150 mg BID with ranitidine 300 mg QID. 96(part 2):A242, 1989","DOI":"10.1111\/j.1365-2036.1989.tb00212.x"},{"issue":"suppl 1","key":"CR17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000199381","volume":"35","author":"N Havu","year":"1986","unstructured":"Havu N: Enterochromatffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric acid secretion. Digestion 35(suppl 1):42?55, 1986","journal-title":"Digestion"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0165-7992(91)90109-H","volume":"262","author":"C Furihata","year":"1991","unstructured":"Furihata C, Matsushima H, Matsushima T: Genotoxicity and cell proliferative activity of omeprazole in rat stomach mucosa. Mutat Res 262:73?76, 1991","journal-title":"Mutat Res"},{"issue":"3","key":"CR19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0016-5085(90)90963-2","volume":"99","author":"D Diaz","year":"1990","unstructured":"Diaz D, Fabre I, Daujat M, Saint Aubert B, Bories P, Michel H, Maurel P: Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P-450. Gastroenterology 99(3):737?747, 1990","journal-title":"Gastroenterology"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000199818","volume":"42","author":"V Savarino","year":"1989","unstructured":"Savarino V, Mela GS, Zentilin P, Cutela P, Mele R, Celle G: Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. Digestion 42:1?6, 1989","journal-title":"Digestion"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01300384.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01300384\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01300384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T08:11:50Z","timestamp":1706083910000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01300384"}},"subtitle":["A six-week, multicenter, randomized, double-blind comparison"],"short-title":[],"issued":{"date-parts":[[1992,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1992,6]]}},"alternative-id":["BF01300384"],"URL":"https:\/\/doi.org\/10.1007\/bf01300384","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[1992,6]]}}}